220 related articles for article (PubMed ID: 31038395)
21. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.
Yun K; Fidler AE; Eccles MR; Reeve AE
Cancer Res; 1993 Nov; 53(21):5166-71. PubMed ID: 8221652
[TBL] [Abstract][Full Text] [Related]
22. Blastemal expression of type I insulin-like growth factor receptor in Wilms' tumors is driven by increased copy number and correlates with relapse.
Natrajan R; Reis-Filho JS; Little SE; Messahel B; Brundler MA; Dome JS; Grundy PE; Vujanic GM; Pritchard-Jones K; Jones C
Cancer Res; 2006 Dec; 66(23):11148-55. PubMed ID: 17145858
[TBL] [Abstract][Full Text] [Related]
23. Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2.
Li MH; Sanchez T; Pappalardo A; Lynch KR; Hla T; Ferrer F
Mol Cancer Res; 2008 Oct; 6(10):1649-56. PubMed ID: 18922980
[TBL] [Abstract][Full Text] [Related]
24. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
[TBL] [Abstract][Full Text] [Related]
25. Identical genetic changes in different histologic components of Wilms' tumors.
Zhuang Z; Merino MJ; Vortmeyer AO; Bryant B; Lash AE; Wang C; Deavers MT; Shelton WF; Kapur S; Chandra RS
J Natl Cancer Inst; 1997 Aug; 89(15):1148-52. PubMed ID: 9262253
[TBL] [Abstract][Full Text] [Related]
26. Association of E2F3 expression with clinicopathological features of Wilms' tumors.
An Q; Wang Y; An R; Li Y; Yao T; Zhai B; Sun X
J Pediatr Surg; 2013 Nov; 48(11):2187-93. PubMed ID: 24210184
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-215-5p Inhibits the Proliferation and Migration of Wilm's Tumor Cells by Targeting CRK.
Li W; Lingdi L; Xiqiang D; Jiheng L; Xin T; Qin H; Haisha L
Technol Cancer Res Treat; 2021; 20():15330338211036523. PubMed ID: 34384283
[TBL] [Abstract][Full Text] [Related]
28. The roles of microRNAs in Wilms' tumors.
Yu X; Li Z; Chan MT; Wu WK
Tumour Biol; 2016 Feb; 37(2):1445-50. PubMed ID: 26634744
[TBL] [Abstract][Full Text] [Related]
29. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
[TBL] [Abstract][Full Text] [Related]
30. Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor.
Rong Y; Cheng L; Ning H; Zou J; Zhang Y; Xu F; Liu L; Chang Z; Fu XY
Cancer Res; 2006 Aug; 66(16):8049-57. PubMed ID: 16912181
[TBL] [Abstract][Full Text] [Related]
31. Geometry of Gene Expression Space of Wilms' Tumors From Human Patients.
Trink A; Kanter I; Pode-Shakked N; Urbach A; Dekel B; Kalisky T
Neoplasia; 2018 Aug; 20(8):871-881. PubMed ID: 30029183
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of Bcl-2 in Wilms' tumor and oncogenic potential of Bcl-X(L) in rare tumor cases.
Re GG; Hazen-Martin DJ; El Bahtimi R; Brownlee NA; Willingham MC; Garvin AJ
Int J Cancer; 1999 Apr; 84(2):192-200. PubMed ID: 10096254
[TBL] [Abstract][Full Text] [Related]
33. miR-194 regulates the proliferation and migration via targeting Hnf1β in mouse metanephric mesenchyme cells.
Liu Y; Hu Y; Ni D; Liu J; Xia H; Xu L; Zhou Q; Xie Y
In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):512-521. PubMed ID: 31144266
[TBL] [Abstract][Full Text] [Related]
34. The yin and yang of kidney development and Wilms' tumors.
Hohenstein P; Pritchard-Jones K; Charlton J
Genes Dev; 2015 Mar; 29(5):467-82. PubMed ID: 25737276
[TBL] [Abstract][Full Text] [Related]
35. Histone deacetylase 5 promotes Wilms' tumor cell proliferation through the upregulation of c-Met.
Cao X; Liu DH; Zhou Y; Yan XM; Yuan LQ; Pan J; Fu MC; Zhang T; Wang J
Mol Med Rep; 2016 Mar; 13(3):2745-50. PubMed ID: 26847592
[TBL] [Abstract][Full Text] [Related]
36. MiR-429 regulates the proliferation and apoptosis of nephroblastoma cells through targeting c-myc.
Wang HF; Wang WH; Zhuang HW; Xu M
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5172-5179. PubMed ID: 30178838
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical expression of p53 proteins in Wilms' tumour: a possible association with the histological prognostic parameter of anaplasia.
Cheah PL; Looi LM; Chan LL
Histopathology; 1996 Jan; 28(1):49-54. PubMed ID: 8838120
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA MIAT acts as an oncogene in Wilms' tumor through regulation of DGCR8.
Zhao XS; Tao N; Zhang C; Gong CM; Dong CY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10257-10263. PubMed ID: 31841180
[TBL] [Abstract][Full Text] [Related]
39. miR-590 regulates WT1 during proliferation of G401 cells.
Hong L; Zhao X; Shao X; Zhu H
Mol Med Rep; 2017 Jul; 16(1):247-253. PubMed ID: 28498419
[TBL] [Abstract][Full Text] [Related]
40. Association between different levels of lipid metabolism‑related enzymes and fatty acid synthase in Wilms' tumor.
Wang X; Du G; Wu Y; Zhang Y; Guo F; Liu W; Wu R
Int J Oncol; 2020 Feb; 56(2):568-580. PubMed ID: 31894270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
